Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection.
about
Structural determinants and mechanism of HIV-1 genome packagingCoordination of Genomic RNA Packaging with Viral Assembly in HIV-1HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchThe matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag.HIV-1 Gag extension: conformational changes require simultaneous interaction with membrane and nucleic acidOpposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome.The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus.Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: implications for genomic RNA packagingRNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus productionMatrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.Roles played by acidic lipids in HIV-1 Gag membrane bindingNucleic acid chaperone activity of retroviral Gag proteinsFeatures, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells.Membrane binding and subcellular localization of retroviral Gag proteins are differentially regulated by MA interactions with phosphatidylinositol-(4,5)-bisphosphate and RNA.Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 GagMolecular determinants that regulate plasma membrane association of HIV-1 GagHIV-1 matrix protein binding to RNA.Solution properties of murine leukemia virus gag protein: differences from HIV-1 gag.Role of the HIV-1 Matrix Protein in Gag Intracellular Trafficking and Targeting to the Plasma Membrane for Virus Assembly.Phosphatidylinositol-(4,5)-Bisphosphate Acyl Chains Differentiate Membrane Binding of HIV-1 Gag from That of the Phospholipase Cδ1 Pleckstrin Homology DomainBeyond plasma membrane targeting: role of the MA domain of Gag in retroviral genome encapsidation.New insights into HIV assembly and trafficking.Functional redundancy in HIV-1 viral particle assembly.Analysis of small molecule ligands targeting the HIV-1 matrix protein-RNA binding site.Translation from nonautonomous type IAP retrotransposon is a critical determinant of transposition activity: implication for retrotransposon-mediated genome evolution.Glutamic Acid Residues in HIV-1 p6 Regulate Virus Budding and Membrane Association of Gag.Evidence in support of RNA-mediated inhibition of phosphatidylserine-dependent HIV-1 Gag membrane binding in cells.Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assemblyDistinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3CIn-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leaderThe nucleocapsid region of human immunodeficiency virus type 1 Gag assists in the coordination of assembly and Gag processing: role for RNA-Gag binding in the early stages of assembly.Methods to Study Determinants for Membrane Targeting of HIV-1 Gag In Vitro.Role of murine leukemia virus nucleocapsid protein in virus assembly.Retroviral matrix and lipids, the intimate interaction.
P2860
Q24632055-665AAB64-72BF-438E-98D1-E158175B04C7Q26739673-FD4CDDEA-9F28-48DE-BEBE-7A6830924D3DQ26746070-6AA1562B-1EC9-4225-B7FB-2EBBF18499CBQ27303006-7C7AE593-FC34-4951-9065-2A0AAD1FBDCEQ30397032-4E8BA486-D3C5-4982-9DC8-93D3ADDA0CADQ33667586-5A26F96D-FB57-4BC0-B30D-F0BD2EEC2166Q33900316-FAB11CDB-DEC9-4A27-8B94-A1C6E77285DDQ34123957-20FA3907-8971-4514-AD88-191AE10E6EF6Q34320638-7323964E-0652-4E6C-8E1E-D6C6F10AD35BQ34361509-D4078AAB-C745-4CC2-96BF-C66F4BAD58F3Q34384875-6B3AF746-B242-4565-A9B5-05E32EF6586DQ34457815-D092121D-63B7-4CF6-92EC-C50F09ABF46EQ34529887-37066818-87D0-4701-A42B-200A5E672362Q34615838-7C11FA26-92CA-4217-BE0F-7A088A61E79CQ34775645-9D789161-8F0A-41D5-97B6-A52DB1C8CB50Q34775654-409C02A5-9CE2-435E-9567-304FEE241EE5Q34976852-EEFED647-2132-4217-85FA-AA151E63CE3DQ34987465-1DA7F028-D892-423C-904A-9D0A33F8B783Q35072137-300999DD-0A57-4085-B70B-8E02443D85C9Q35076588-C4CA13FE-2E24-4B13-AEF3-BA3FBC27D84CQ35113734-A8F0B8BE-8032-4DF5-8B49-B8A58B3918D2Q35114688-72E77F6D-A9D6-437C-AFDA-EED4087DB76CQ35531426-F1CB0440-9954-447D-B71C-65DE1F2642EDQ35761675-EBBC4C88-EA71-4ABC-95D0-777FB5084A01Q35861246-0FCE5F7D-8CFA-4815-8F40-7755F7425A22Q35893976-7F1DB559-1BCD-4B22-A099-A8ADCBC0BCFCQ36307738-26F1BA88-B4CE-4D19-B430-D35B0D5FBE0AQ36397587-68075424-E6F0-4183-B887-AEF20869C2B7Q36508756-A34D3FF4-82BD-4AE1-B647-B8040BE7FDE4Q36700161-D1A8D594-D840-44B6-8103-7B66E83F4A88Q36846049-E46FC6F3-202A-40B2-B7E5-BF2439751C60Q36911677-287CCE5C-937A-4A70-8E4C-21CEF3930793Q36950860-C08492BD-7E56-4D3D-83AF-2F9E9BFAF880Q37099669-537DA197-2DC4-46EB-AB18-DEE250C32FB2Q37217808-7D9DBF3D-A911-4D9F-A7D0-15DA6795CEB7Q37224783-D1927D90-CDE9-405C-BE3D-D2414F09511FQ37256729-06EE764B-FCC1-4A13-B40A-7E6600AFD165Q37272001-8AF91B10-F637-4257-B665-252B84728F00Q37596946-18980F79-57C1-4F72-B3F8-7CAAEE98C810Q37850839-BC93FDAC-D6FF-4F4C-9C61-E82853828EEB
P2860
Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Sequence-specific interaction ...... by in vitro genetic selection.
@ast
Sequence-specific interaction ...... by in vitro genetic selection.
@en
Sequence-specific interaction ...... by in vitro genetic selection.
@nl
type
label
Sequence-specific interaction ...... by in vitro genetic selection.
@ast
Sequence-specific interaction ...... by in vitro genetic selection.
@en
Sequence-specific interaction ...... by in vitro genetic selection.
@nl
prefLabel
Sequence-specific interaction ...... by in vitro genetic selection.
@ast
Sequence-specific interaction ...... by in vitro genetic selection.
@en
Sequence-specific interaction ...... by in vitro genetic selection.
@nl
P2093
P2860
P1433
P1476
Sequence-specific interaction ...... by in vitro genetic selection.
@en
P2093
P2860
P304
P356
10.1017/S1355838201002023
P407
P577
2001-04-01T00:00:00Z